Dr. Temi Folaranmi is Vice President and Therapeutic Area Lead for Vaccines Medical and Clinical Affairs at GSK in the United States. In his current role, he provides strategic leadership to a team of physicians, pharmacists, epidemiologists, and health outcome scientists engaging with various vaccine stakeholders to inform scientific knowledge and utilization of vaccines for disease prevention. He serves as the senior vaccine’s physician for GSK in the United States and scientific spokesperson for GSK Vaccines where necessary. Temi is also the industry representative on FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC)
· 2026 key disease focus areas for vaccine manufacturers, upcoming approvals 2026
· What next generation vaccine platforms have the most impact/potential – why?
· Strengthening public-private collaborations – new partnership opportunities of interest